Lori Reilly

Pharmaceutical Research and Manufacturers of America

Guest

Vice president of policy and research for the Pharmaceutical Research and Manufacturers of America,  which represents leading research-based pharmaceutical companies in the US

Lori Reilly on KCRW

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

The Rising Cost of Fighting Cancer

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

from To the Point

Patents are about to expire on two of the world's best-selling prescription drugs.

Expiring Patents, Drug Prices and the Hazy Market for Generics

Patents are about to expire on two of the world's best-selling prescription drugs.

from To the Point

More from KCRW

Will Donald Trump reduce U.S. interventionism? Did President Biden open a can of worms by pardoning his son Hunter? Plus, KCRW looks at what justice means post-election.

from Left, Right & Center

Much needed attention has been brought upon the for-profit health insurance industry in the wake of the assassination of UnitedHealthcare CEO Brian Thompson.

from Scheer Intelligence

Former Orange County Supervisor Andrew Do has agreed to plead guilty to federal corruption charges after prosecutors say he accepted more than half a million dollars in bribes.

from KCRW Features

KCRW examines Donald Trump’s cabinet picks. Is the GOP misreading an immigration “mandate” from voters? Plus, is America just not ready for a woman president?

from Left, Right & Center

The outcome of congressional races in Orange County could determine whether Republicans keep their majority in the House of Representatives.

from KCRW Features

Young progressives with Chispa rallied Latino voters for Democrat Derek Tran in OC’s 45th District, a race that hasn’t been called.

from KCRW Features

In the 365 days following the events of Oct. 7, the situation in the Middle East is as complicated as ever.

from Scheer Intelligence

New polling shows Americans feel less divided post-election. Can Donald Trump “end all wars” this term? Plus, KCRW analyzes the future of the progressive agenda.

from Left, Right & Center

Should the U.S. worry about post-Assad Syria? What’s behind the support for the man who fatally shot UHC’s CEO? Plus, KCRW discusses how sports fandom crossed into politics.

from Left, Right & Center